Introduction
Unselective dietary protein energy supplementation of all Asian mothers at Sorrento Maternity Hospital irrespective of nutritional state during the second and third trimesters of pregnancy did not enhance intrauterine growth. ' This study examines the effect of selective supplementation-that is, in which dietary supplements were given to mothers during the third trimester if anthropometric evidence of undernutrition had been detected in the second trimester. It also describes the effect of giving supplements to mothers who had no preceding evidence of undernutrition.
Methods

PLAN OF TRIAL
We recruited to the trial 130 women who booked between 5 November 1979 and 11 June 1980 before 20 weeks of gestation, who lived within a defined area of the City of Birmingham (covered by domiciliary midwives' areas 9 and 10, Birmingham Area Health Authority (Teaching)), and who gave informed consent. They entered the trial at 18 to 20 weeks but received only iron (3 mg daily) and vitamin C (30 mg daily) until 28 weeks (fig 1) . The mothers were then divided into (a) those who from evidence of other work at this hospital2 were nutritionally at risk of having a light for gestational age baby as shown by an inadequate increase in triceps skinfold thickness increment (<20 ,um/week during the second trimester; n = 45), and (b) those with an adequate increase in triceps skinfold thickness increment (>20 ,m/week) during the second trimester; these are referred to as adequately nourished (n = 85). SUPPLEMENTATION Consumption of the protein energy supplement led to improved intrauterine growth in women who were at nutritional risk of having a poorly grown baby. Three points require consideration before accepting this conclusion. The PrEnVi group contained more Hindus but, since they tend to have a lower birth weight, this would not have given the PrEnVi group any advantage. When the patients are divided according to supplement and triceps skinfold thickness increment the numbers in the subgroups are relatively small, but the twotailed statistical significance of differences between the small subgroups is given. We therefore regard the conclusion as valid. Was the protein energy by itself responsible for the enhanced growth or could it have been due to protein alone or some micronutrient within the chocolate-skimmed milk powder? This cannot be excluded with certainty but, since the results in the EnVi group were mostly midway -between those of the PrEnVi and Vi groups, it seems more likely that the "nutrient" which enhanced growth in this study was balanced protein energy.
COMPARISON WITH OTHER SUPPLEMENTATION STUDIES
In some early studies improved diet was not the only variable since it was often accompanied by increased obstetric care. In the past 10 years there have been four other major supplementation studies6-9 with variation in choice of controls and methods to check compliance and exclusion policy etc. The major features of these studies are given in table C (available on request).
We suggest that the results of our study-namely, a differential effect of supplementation depending on the mothers' nutritional state during the second trimester-may explain the apparently conflicting results of the other studies. Some showed a substantial effect-for example, in Guatemala6 and Colombia7; we suspect that most of these mothers were nutritionally at risk. 594 Others had only a small effect-for example, in New York8 and Taiwan9; we suspect that very few of these mothers were nutritionally at risk of having a poorly grown baby.
IMPLICATIONS FOR INTERVENTION POLICY
Clearly this and our other study ' show that it would be inappropriate to give supplements to all Asian mothers. Selection is essential. An inadequate gain in triceps skinfold thickness during the second trimester seems a suitable method for identifying the nutritionally at-risk mothers. Since the increase in triceps skinfold thickness represents, in effect, a person's energy balance we suspect that this is a better indicator of nutritional risk than assessment of dietary intake, but we are studying this further. The method is certainly simple, cheap, and applicable to large numbers of patients, but unfortunately it will not be possible to apply this to mothers booking very late. Once the mother is selected at 28 weeks as being nutritionally at risk, should she be given a supplement-the logistics are daunting-or would dietary advice alone do?
Ways of expanding these experimental observations into a routine service are being examined. The incidence of penicillamine toxicity was determined in 250 patients who had never previously received gold, 76 patients who had received gold without toxic reaction, and 79 patients with a previous history of gold toxicity. The results suggest that there may be a higher incidence of penicillamine toxicity in patients who have previously shown toxic reactions. The interval between stopping the gold and starting the penicillamine did not influence incidence of toxicity. The development of a rash during gold treatment does not seem to influence the development of a rash during penicillamine treatment, but patients who have had proteinuria or bone-marrow depression during gold treatment may have an increased likelihood of developing a similar side effect with penicillamine.
Introduction
There have been conflicting reports on the effect of previous gold treatment on the subsequent development of penicillamine toxicity. The multicentre trial group found no increased toxicity in patients who had previously received gold treatment. ' Webley and Coomes also reported no overall increase in the incidence of side effects, but rashes and possibly bone-marrow depression were commoner in patients who had previously received gold.2 Dodd et al found an increased penicillamine toxicity in patients who had previously had adverse reactions to gold and also an increased risk if the penicillamine was given within six months of stopping the gold.3 Steven et al concluded that there was no increased incidence of toxic reaction to second-line drugs in patients who had previously been treated with gold or penicillamine and that the interval between the drugs had no influence on the outcome.4
Patients, methods, and results
The records of 405 patients with rheumatoid arthritis who had been given penicillamine were studied. A total of 250 had never received gold, 76 had received gold without adverse effects, and 79 had a history of gold toxicity. In all cases of toxicity the side effects were-considered sufficiently severe to stop the drug; mild or transient side effects have not been included. Patients with upper gastrointestinal
